Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SIKA OPENS STATE-OF-THE-ART PRODUCTION AND CONCRETE SERVICE HUB IN THE BENELUX REGION Sika expands its production and innovation capabilities in Europe by commissioning a new plant and technical...
-
SIKA ERÖFFNET HOCHMODERNES PRODUKTIONS- UND BETON-SERVICE-ZENTRUM IN DER BENELUX-REGIONSika baut ihre Produktions- und Innovationskapazitäten in Europa aus und nimmt im belgischen Ham ein neues Werk...
-
Ad hoc announcement pursuant to Art. 53 LR Senior secured term loan of up to CHF 250 million with a 5‑year maturity at a fixed 7% interest rateFirst tranche will fully refinance the existing New...
-
Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), June 9, 2026 dsm-firmenich, innovators in...
-
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
Results from Rhapsido (remibrutinib) pivotal Phase III RemIND trial, the largest study in chronic inducible urticaria, to be highlighted in late-breaker oral presentationNew Phase IIIb REMIXED...
-
Agreement offers potential best-in-class targeted protein degrader therapy option for people living with B-cell malignanciesCollaboration adds to Roche’s oncology pipeline and offers potential...
-
WISeKey, The Hashgraph Group and Hedera Launch QAIT Q-Day Security Assessment Platform on the SEALCOIN Quantum Marketplace First Quantum Security Service to Launch Within SEALCOIN’s Dedicated...
-
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 5, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio...
-
Phase III ALIGN study results showed reduced rate of kidney function decline by ~34% with Vanrafia vs placebo, based on supportive eGFR slope analysis1Vanrafia reduced protein in urine by 38.3% vs...
-
MEDIA RELEASE Muttenz, 4 June 2026 Clariant, a sustainability-focused specialty chemical company, today announced the successful placement of EUR 500 million in unsecured Eurobonds issued by its...